ADR120S, Inc. (TYO:3750)
Japan · Delayed Price · Currency is JPY 869.00
+1.00 (0.12%)
At close: Feb 6, 2026
ADR120S Market Cap
ADR120S has a market cap or net worth of 7.76 billion as of February 6, 2026. Its market cap has decreased by -2.03% in one year.
Market Cap
7.76B
Enterprise Value
7.52B
Revenue
49.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
869.00
Market Cap Chart
Since June 28, 2006, ADR120S's market cap has decreased from 8.22B to 7.76B, a decrease of -5.60%. That is a compound annual growth rate of -0.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 7.76B | 3.45% |
| Dec 30, 2025 | 7.50B | -2.89% |
| Dec 30, 2024 | 7.72B | -24.06% |
| Dec 29, 2023 | 10.17B | -6.18% |
| Dec 30, 2022 | 10.84B | -4.64% |
| Dec 30, 2021 | 11.37B | -10.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| StemCell Institute | 8.76B |
| CellSource | 8.27B |
| K Pharma,Inc. | 7.99B |
| MEDINET | 7.94B |
| Chiome Bioscience | 7.73B |
| BrightPath Biotherapeutics | 7.68B |
| OncoTherapy Science | 7.53B |
| Linical | 7.09B |